Adverse prognosis associated with asymmetric myocardial thickening in aortic stenosis.
Adverse prognosis associated with asymmetric myocardial thickening in aortic stenosis.
复制标题
DOI:
10.1093/ehjci/jex052
复制
发表时间:
2018-03-01
期刊:
影响因子:
--
通讯作者:
Dweck MR
中科院分区:
文献类型:
--
作者:
Kwiecinski J;Chin CWL;Everett RJ;White AC;Semple S;Yeung E;Jenkins WJ;Shah ASV;Koo M;Mirsadraee S;Lang CC;Mills N;Prasad SK;Jansen MA;Japp AG;Newby DE;Dweck MR
Asymmetric wall thickening has been described in patients with aortic stenosis. However, it remains poorly characterized and its prognostic implications are unclear. We hypothesized this pattern of adaptation is associated with advanced remodelling, left ventricular decompenzation, and a poor prognosis. In a prospective observational cohort study, 166 patients with aortic stenosis (age 69, 69% males, mean aortic valve area 1.0 ± 0.4 cm2) and 37 age and sex-matched healthy volunteers underwent phenotypic characterization with comprehensive clinical, imaging, and biomarker evaluation. Asymmetric wall thickening on both echocardiography and cardiovascular magnetic resonance was defined as regional wall thickening ≥ 13 mm and > 1.5-fold the thickness of the opposing myocardial segment. Although no control subject had asymmetric wall thickening, it was observed in 26% (n = 43) of patients with aortic stenosis using magnetic resonance and 17% (n = 29) using echocardiography. Despite similar demographics, co-morbidities, valve narrowing, myocardial hypertrophy, and fibrosis, patients with asymmetric wall thickening had increased cardiac troponin I and brain natriuretic peptide concentrations (both P < 0.001). Over 28 [22, 33] months of follow-up, asymmetric wall thickening was an independent predictor of aortic valve replacement (AVR) or death whether detected by magnetic resonance [hazard ratio (HR) = 2.15; 95% confidence interval (CI) 1.29–3.59; P = 0.003] or echocardiography (HR = 1.79; 95% CI 1.08–3.69; P = 0.021). Asymmetric wall thickening is common in aortic stenosis and is associated with increased myocardial injury, left ventricular decompenzation, and adverse events. Its presence may help identify patients likely to proceed quickly towards AVR. https://clinicaltrials.gov/show/NCT01755936: NCT01755936.
登录
查看更多内容
DOI:
10.1186/1532-429x-14-50
发表时间:
2012-07-28
期刊:
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子:
--
作者:
Dweck MR;Joshi S;Murigu T;Gulati A;Alpendurada F;Jabbour A;Maceira A;Roussin I;Northridge DB;Kilner PJ;Cook SA;Boon NA;Pepper J;Mohiaddin RH;Newby DE;Pennell DJ;Prasad SK
通讯作者:
Prasad SK
影响因子:
37.8
作者:
MARON, BJ;CLARK, CE;EPSTEIN, SE
通讯作者:
EPSTEIN, SE
影响因子:
6.2
作者:
Lang, Roberto M.;Badano, Luigi P.;Voigt, Jens-Uwe
通讯作者:
Voigt, Jens-Uwe
影响因子:
6.4
作者:
Maceira, A. M.;Prasad, S. K.;Pennell, D. J.
通讯作者:
Pennell, D. J.
影响因子:
39.3
作者:
Chin, Calvin W. L.;Shah, Anoop S. V.;Dweck, Marc R.
通讯作者:
Dweck, Marc R.